Investor insights
Sectors invested in
Biotechnology2
NASH1
알레르기1
Immuno-Oncology1
단백질 신약1
바이오제약1
신약 개발1
항암1
Health Care1
Clinical development1
neoantigens1
Plasmacytoid Dendritic Cells1
Therapeutic vaccines1
Therapeutics1
Cancer immunotherapy1
Funding rounds participated in
$44M sweet spot round size
Most of their 3 investments are in rounds between $13M and $44M
Investor type
Hedge Fund
Basic info
Date founded
2009
Investments made
P
PDC*line Pharma raised $13M on December 6, 2021
Investors: -, Korea Investment Partners, SRIW, ALPHACHIPS Corp, UTC Investment Co.,Ltd., SFPI-FPIM and Brain Asset Management
G
GI Innovation raised $143M on June 15, 2021
Investors: DAYLI Partners, AJU IB INVESTMENT, NH Investment & Securities, DS Asset Management and Brain Asset Management
U
Undisclosed raised $44M on June 15, 2021
Investors: Korea Investment Partners, Industrial Bank of Korea, Kiwoom Securities Indonesia and Brain Asset Management